Alexandra Glucksmann, PhD
Alexandra Glucksmann is an Entrepreneur-in-Residence at Third Rock Ventures in Boston, Massachusetts. She is focused on new company formation. She has nearly 25 years of R&D leadership and operations experience. Most recently, Alexandra served as chief operating officer of Editas Medicine Inc., which she joined as a founder and first employee. Editas is a gene editing company whose mission is to translate its genome editing technology into a novel class of human therapeutics. Previously, she was senior vice president of R&D at Cerulean Pharma, which she also joined at its founding. Prior to joining Cerulean in 2006, she spent 13 years at Millennium Pharmaceuticals, which she joined in 1993 as one of its first scientists. At Millennium, she held a series of science positions with increasing responsibility, ultimately becoming vice president of all platform technology groups before moving into a senior role in strategic program management and operations. Alexandra serves on the board of Women in the Enterprise of Science and Technology (WEST). She was a post-doctoral fellow at the Massachusetts Institute of Technology and holds a Ph.D. with honors from the University of Chicago.